GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM(TM))
Keep up with the latest news and announcements from the GB Sciences team
Watch this short video of GBLX CEO John Poss as he fields questions from the web
Watch this short video of GBLX CEO John Poss as he fields questions from the web
Watch this short video of GBLX CEO John Poss as he fields questions from the web
Watch this short video of GBLX CEO John Poss as he fields questions from the web
Watch this short video of GBLX CEO John Poss as he fields questions from the web
Watch this short video of GBLX CEO John Poss as he fields questions from the web
How did they balance being so funny and being such respected artists?” This question was recently posed by a visitor in reference
How did they balance being so funny and being such respected artists?” This question was recently posed by a visitor in reference
How did they balance being so funny and being such respected artists?” This question was recently posed by a visitor in reference